Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Gift CEO and President gave 8,563 shares (gift)
  2. 4 Open-market sale 10% owner sold 11,396 shares at $2.44 ($27,828)
  3. 4 Open-market sale 10% owner sold 74,551 shares at an average $2.36 ($175,842)
  4. 4 Open-market sale 10% owner sold 8,288 shares at $2.12 ($17,598)
  5. 4 Open-market sale 10% owner sold 64,568 shares at an average $2.21 ($142,503)
  6. 4 Open-market sale 10% owner sold 12,725 shares at $2.26 ($28,734)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale 10% owner sold 15,054 shares at an average $2.92 ($44,008)
  16. 4 Open-market sale 10% owner sold 42,800 shares at an average $3.05 ($130,434)
  17. 4 Open-market sale 10% owner sold 70,885 shares at an average $3.25 ($230,326)
  18. 4 Open-market sale 10% owner sold 182,300 shares at an average $3.11 ($566,951)
  19. 4 Shares withheld for taxes CEO and President gave up 7,803 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Medical Officer gave up 2,879 shares (to pay taxes)

Page 4 of 20 · 382 filings